{
    "Clinical Trial ID": "NCT02725801",
    "Intervention": [
        "INTERVENTION 1: ",
        "  One-port",
        "  intervention is placement of one-port tissue expander at time of reconstruction",
        "  Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction",
        "INTERVENTION 2: ",
        "  Two-port",
        "  intervention is placement of two-port tissue expander at time of reconstruction",
        "  AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  patient agrees to immediate tissue expander breast reconstruction",
        "  a suitable patient for tissue expander reconstruction",
        "Exclusion Criteria:",
        "  not a surgical candidate for immediate breast reconstruction",
        "  age less than 18",
        "  patient declines tissue expander reconstruction",
        "  patient anticipated to need radiation therapy postoperatively"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant",
        "  The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared",
        "  Time frame: 3 months",
        "Results 1: ",
        "  Arm/Group Title: One-port",
        "  Arm/Group Description: intervention is placement of one-port tissue expander at time of reconstruction",
        "  Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction",
        "  Overall Number of Participants Analyzed: 8",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  8 100.0%",
        "Results 2: ",
        "  Arm/Group Title: Two-port",
        "  Arm/Group Description: intervention is placement of two-port tissue expander at time of reconstruction",
        "  AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction",
        "  Overall Number of Participants Analyzed: 12",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  12 100.0%"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 1/8 (12.50%)",
        "  re-operation [1]1/8 (12.50%)",
        "Adverse Events 2:",
        "  Total: 4/12 (33.33%)",
        "  re-operation [1]4/12 (33.33%)"
    ]
}